SEP 17, 2015 05:08 PM PDT

Alzheimer's Disease Has Three Distinct Subtypes

Contrary to previous thinking, Alzheimer’s disease consists of three distinct subtypes, according to a UCLA study. The discovery could mean more highly targeted research and, ultimately, new treatments for the neurological disorder.
UCLA study finds three types of Alzheimer's. 
The UCLA study also found that one of the three variations, the cortical subtype, seems to be fundamentally a different condition from the other two, said Dr. Dale Bredesen, the study’s author, a UCLA professor of neurology and member of the Easton Laboratory for Neurodegenerative Disease Research. According to Bredesen, “Because the presentation varies from person to person, there has been suspicion for years that Alzheimer’s represents more than one illness. When laboratory tests go beyond the usual tests, we find these three distinct subtypes. The important implications of this are that the optimal treatment may be different for each group, there may be different causes, and, for future clinical trials, it may be helpful to study specific groups separately.”
 
The subtypes are: 
  • Inflammatory, in which markers such as C-reactive protein and serum albumin to globulin ratios are increased.
  • Non-inflammatory, in which these markers are not increased but other metabolic abnormalities are present.
  • Cortical, which affects relatively young individuals and appears more widely distributed across the brain than the other subtypes of Alzheimer’s. It typically does not seem to cause memory loss at first, but people with this subtype of the disease tend to lose language skills. It is often misdiagnosed, typically affects people who do not have an Alzheimer’s-related gene and is associated with a significant zinc deficiency.

The two-year study, which involved metabolic testing of 50 people, was published in the journal Aging and reported in Bioscience Technology. The article explained that there is no effective therapy for Alzheimer’s, scientists have yet to identify the cause and some studies cite metabolic abnormalities such as insulin resistance, hormonal deficiencies and a high level of an amino acid in the blood.
 
In 2014 Bredesen demonstrated that making lifestyle, exercise and diet changes to improve metabolism reversed cognitive decline in nine out of 10 patients with early Alzheimer’s disease or its precursors. The current finding grew out of an extensive evaluation of data from that study, and it could eventually help scientists to find more precise targets for treatments in the same way they have made advances in treating other diseases. For instance, Bredesen said, researchers have been able to develop precise treatments for cancer by sequencing tumor genomes and comparing them to the patients’ genomes to see what drives the formation and growth of tumors.
 
He added, “However, in Alzheimer’s disease, there is no tumor to biopsy. So how do we get an idea about what is driving the process? The approach we took was to use the underlying metabolic mechanisms of the disease process to guide the establishment of an extensive set of laboratory tests, such as fasting insulin, copper-to-zinc ratio and dozens of others.”
 
Bredesen and his team will now try to determine whether the subtypes have different underlying causes and whether they respond differently to potential treatments.
About the Author
  • Ilene Schneider is the owner of Schneider the Writer, a firm that provides communications for health care, high technology and service enterprises. Her specialties include public relations, media relations, advertising, journalistic writing, editing, grant writing and corporate creativity consulting services. Prior to starting her own business in 1985, Ilene was editor of the Cleveland edition of TV Guide, associate editor of School Product News (Penton Publishing) and senior public relations representative at Beckman Instruments, Inc. She was profiled in a book, How to Open and Operate a Home-Based Writing Business and listed in Who's Who of American Women, Who's Who in Advertising and Who's Who in Media and Communications. She was the recipient of the Women in Communications, Inc. Clarion Award in advertising. A graduate of the University of Pennsylvania, Ilene and her family have lived in Irvine, California, since 1978.
You May Also Like
OCT 29, 2018
Neuroscience
OCT 29, 2018
Zapping the nerves to promote nerve regeneration
Nerve regeneration by electrical stimulation...
OCT 29, 2018
Neuroscience
OCT 29, 2018
Did we get blindsided about the role of cerebellum?
Cerebellum play a mjor role in higher -order brain functions beyond the motor specific functioning...
NOV 12, 2018
Health & Medicine
NOV 12, 2018
Researchers find that obesity has a paradoxical effect on Cancer
Cancer therapy works differently in different people. Understanding what effects the individual body's response to treatment will be crucial for the development...
NOV 13, 2018
Drug Discovery
NOV 13, 2018
Clinical Trial Drug For a Rare Neurodegenrative Disease Proven Unsuccessful
Niemann-Pick type C (NPC) is a rare and fatal neurodegenerative disease. Symptoms of the condition include loss of balance, difficulty swallowing, seizures...
DEC 05, 2018
Cardiology
DEC 05, 2018
The Case For Sexual Healing In Heart Patients
Sex is an important component in the lives of most healthy adults. As such, it is essential for providers working with post-coronary patients to advise the...
NOV 15, 2018
Cannabis Sciences
NOV 15, 2018
Marijuana-Induced Cyclic Vomiting
Trigger warning: If you are a bit squeamish about emesis (vomiting) then this article may not be for you. Otherwise, prepare yourself to learn about a...
Loading Comments...